Genetically modified fibroblast cells

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S325000, C435S357000, C435S366000

Reexamination Certificate

active

06846674

ABSTRACT:
The invention relates to genetically modified fibroblast cells which comprise the following properties: (a) a gene, encoding a subunit of the transcription factor AP-1, of its genome is inactivated and/or a component, acting on the AP-1 transcription factor of the signal transduction pathway is modified resulting in a modified AP-1 activity; (b) functionally linked with a promoter, it contains in an expression vector the gene from (a) in a form such that the active subunit is only expressed after induction of the promoter or the subunit encoded by the gene is present in inactive form and a form that can be activated. Furthermore, the invention relates to a method which uses the fibroblast cell according to the invention to identify a compound which can support, inhibit or modify the AP-1-dependent differentiation and/or proliferation of keratinocytes or a gene which is involved in the AP-1-dependent differentiation and/or proliferation of keratinocytes as well as to the use of the test compound identified according to the method of the invention and the gene for treating or diagnosing diseases associated with a disturbed proliferation and/or differentiation of keratinocytes.

REFERENCES:
patent: 1 055 366 (2000-11-01), None
Johnson et al, Molecular and Cellular Biology, Aug., 1996, vol. 16, No. 8, pp. 4504-4511.*
Chomczynski, Piotr, et al., “Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction”,Analytical Biochemistry, 162, (1987), 156-159.
Riabowol, Karl, et al., “Transcription Factor AP-1 Activity is Required for Initiation of DNA Synthesis and is Lost During Cellular Aging”, PNAS, vol. 89, (1992), 157-161.
Sambrook, J., et al., “5. Enzymes Used in Molecular Cloning”,Molecular Cloning. A Laboratory Manual, (1989),5.1-5.95.
Sambrook, J., et al., “6. Gel Electrophoresis of DNA”,Molecular Cloning. A Laboratory Manual, (1989),6.1-6.2.
Sambrook, J., et al., “9. Analysis and Cloning of Eukaryotic Genomic DNA”,Molecular Cloning. A Laboratory Manual, (1989),9.1-9.62.
Sambrook, J., et al., “Plasmid Vectors—Development of Plasmid Cloning Vectors”,Molecular Cloning. A Laboratory Manual, (1989),1.7-1.10
Todaro, George J., et al., “Quantitative Studies of the Growth of Mouse Embryo Cells in Culture and Their Development into Established Lines”,The Journal of Cell Biology, 17, (1963),299-313.
Turner, David M., “Natural Product Source Material Use in the Pharmaceutical Industry: the Glaxo Experience”,Journal of Ethnopharmacology, 51, (1996),39-44.
Bossy-Wetzel, Ella.,et al. ,“Induction of apoptosis by the transcription factor c-Jun”,EMBO(European Molecular Biology Organization)Journal, vol. 16, No. 7, ISSN 0261-4189 XP002174993,(1997),1695-1709.
Hans-Jurgen, Stark.,et al. ,“Organotypic Keratinocyte Cocultures in Defined Medium with Regular Epidermal Morphogenesis and Differentiation”,Journal of Investigative Dermatology, vol. 112, No. 5 XP-002174997,(May 1999),681-691.
Kovary, Karla.,et al. ,“The Jun and Fos Protein Families Are Both Required for Cell Cycle Progression in Firoblasts”,Molecular and Cellular Biology, vol. 11, No. 9,(Sep. 1991),4466-4472.
Maas-Szabowski, Nicole.,et al. ,“Organotypic Cocultures with Genetically Modified Mouse Fibroblasts as a Tool to Dissect Molecular Mechanisms Regulating Keratinocyte Growth and Differentiation”,Journal of Investigative Dermatology, vol. 116, No. 5 XP-002174999,(May 2001),816-820.
Orlandini, Maurizio,et al. ,“Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family”,Proceedings of the National Academy of Sciences of the United States, vol. 93, No. 21 XP-002174995,(Oct. 1996),11675-11680.
Schorpp-Kistner, Marina.,et al. ,“JunB is essential for mammalian placentation”,EMBO Journal; Oxford University Press, Surrey, GB, vol. 18, No. 4 XP-002121786,(Feb. 15, 1999),934-948.
Schreiber, Martin.,et al. ,“Control of cell cycle progression by c-June is p53 dependent”,Genes&Development, vol. 13, No. 5 XP002174994,(Mar. 1, 1999),607-619.
Superti-Furga, Giulio.,et al. ,“Hormone-dependent transcriptional regulation and cellular transformation by Fos-steroid receptor fusion proteins”,Proceedings of the National Academy of Sciences of the United States, vol. 88, No. 12 XP-002174996,(1991),5114-5118.
Szabowski, Axel.,et al. ,“c-Jun and JunB Antogonistically Control Cytokine-Regulated Mesenchymal-Epidermal Interaction in Skin”,CELL, vol. 103, No. 5 XP002174998,(Nov. 22, 2000),745-755.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Genetically modified fibroblast cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genetically modified fibroblast cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetically modified fibroblast cells will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3412952

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.